| Benjamin Jorgensen, | |
|
123 Medical Center Dr, Brunswick, ME 04011-2652 | |
| (207) 373-6000 | |
| Not Available |
| Full Name | Benjamin Jorgensen |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 11 Years |
| Location | 123 Medical Center Dr, Brunswick, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932630290 | NPI | - | NPPES |
| MD26999 | Other | ME | LICENSE |
| D91702 | Other | MD | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D91702 (Maryland) | Secondary |
| 207L00000X | Anesthesiology | MD26999 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mid Coast Hospital | Brunswick, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Healthcare Partners Pa | 7618871245 | 265 |
News Archive
Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.
In a recent study, babies who were large at birth had an increased likelihood of being obese when they were in kindergarten to second grade (age 5 to 8 years).
An elaborate statistical analysis of genes from more than 7,000 individuals has identified an amino acid that appears to be a major risk factor for multiple sclerosis, a devastating autoimmune disorder that afflicts 2.5 million people worldwide.
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).
› Verified 8 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040127000198 |
News Archive
Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.
In a recent study, babies who were large at birth had an increased likelihood of being obese when they were in kindergarten to second grade (age 5 to 8 years).
An elaborate statistical analysis of genes from more than 7,000 individuals has identified an amino acid that appears to be a major risk factor for multiple sclerosis, a devastating autoimmune disorder that afflicts 2.5 million people worldwide.
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).
› Verified 8 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040915000845 |
News Archive
Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.
In a recent study, babies who were large at birth had an increased likelihood of being obese when they were in kindergarten to second grade (age 5 to 8 years).
An elaborate statistical analysis of genes from more than 7,000 individuals has identified an amino acid that appears to be a major risk factor for multiple sclerosis, a devastating autoimmune disorder that afflicts 2.5 million people worldwide.
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Jorgensen, 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: (410) 933-6421 | Benjamin Jorgensen, 123 Medical Center Dr, Brunswick, ME 04011-2652 Ph: (207) 373-6000 |
News Archive
Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.
In a recent study, babies who were large at birth had an increased likelihood of being obese when they were in kindergarten to second grade (age 5 to 8 years).
An elaborate statistical analysis of genes from more than 7,000 individuals has identified an amino acid that appears to be a major risk factor for multiple sclerosis, a devastating autoimmune disorder that afflicts 2.5 million people worldwide.
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).
› Verified 8 days ago
Andrew L Rabinowitz, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Anna Katarina Sawtelle, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
John M. Seely, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 14 Thomas Point Rd, Brunswick, ME 04011 Phone: 207-442-0325 | |
Byron P Hathcock, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6150 | |
Ronald E Chicoine, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Irl L Rosner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
John L Crispin, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 |